rad T. Sauer Executive Vice President, Health Care Business

Accelerating Growth In Health Care

Brad Sauer
Executive Vice President,
Health Care Business

3M Investor Meeting 2006 © 3M 2006 All Rights Reserved

3M Healthcare: Key Financial Data
Sales Operating Income
$1,200
$5.0
$Billions & YOY % Chg $Millions & YOY % Chg $1,114
+15%
$973
$3.8 $907
$4.0
+7%
$3.4 $3.6 $900
+5% +5% +20%*
+12%
$3.0
$600
$2.0
$298
$1.0 $300
$1.0
+10%
+2%
$0
$0.0
2003 2004 2005 Q1 2006
2003 2004 2005 Q1 2006

LC Growth 5.3% .6% 4.2% 4.9% OI Margin 26.4% 27% 29.6% 30.8%

2005 Sales By Geographic Area
U.S. 47%

LAC 7%

APAC 11%
Europe 35%
*2002 estimated stock options, not restated.


Health Care Growth Strategy

STEP 1 STEP 2

Accelerate
Reconfigure the
Portfolio Growth

REDIRECT RESOURCES


Health Care Portfolio Reconfiguration
Health
Drug
Dental &
Information Personal
Delivery
Medical Orthodontics Pharma
Systems Care
Systems

Focused Portfolio Of Strength
Leverage
Pursue
Investment
Increase R&D For New Products
Strategic 3M I&TB Supply
Redirection
Expand Sales Coverage
Chains &
Alternatives
Penetrate Developing Countries
Technologies
Synergistic Acquisitions

Pharmaceuticals Business Direction
3M is exploring strategic alternatives for its global branded
pharmaceuticals business and IRM platform (Goldman Sachs
retained)
Today’s very competitive pharmaceutical marketplace requires
broad pipelines of new drugs, significant investments, and a
longer term risk-reward business model than applies to most
other 3M businesses
Very successful business but different model and not core for 3M
The best way for our branded pharmaceuticals business to
succeed is for it to be free to pursue separate strategies under
the direction of a dedicated pharmaceutical industry company
with a business model better suited to maximize its potential


Health Care Reconfigured Portfolio
Health
Drug
Dental &
Information
Delivery
Medical Orthodontics Systems
Systems

Investment

Focused Portfolio of Strength
Increase R&D For New Products
Expand Sales Coverage
Penetrate Developing Countries
Synergistic Acquisitions

Health Care Growth Strategy

STEP 1 STEP 2

Reconfigure the Accelerate
Growth
Portfolio

REDIRECT RESOURCES


Health Care Growth Strategies
Drive additional organic growth with key
investments
– R&D for new products
– Expanded sales coverage and marketing globally

Accelerate in high growth market spaces with new
organic platforms
Rapidly penetrate developing countries


Rapidly Penetrating Developing Countries
2005 Local
HCB Revenues Currency Growth

China 35%
Developed
Countries*
Venezuela 34%
Expanded Sales
Russia 32%
Coverage
Turkey 25%
New Products
Malaysia 25%
Tailored To
Market Needs Argentina 24%
India 22%
Local
Manufacturing Thailand 19%
Taiwan 19%
Developing
Gulf 14%
Countries
South Africa 13%
Mexico 12%
*U.S., Canada, Western Europe, Japan, Australia, New Zealand
Brazil 10%


Health Care Growth Strategies
Drive additional organic growth with key
investments

Accelerate in high growth market spaces with new
organic platforms
Rapidly penetrate developing countries
Step up the pace on acquisitions, especially
synergistic bolt-ons


Medical Division Portfolio
Infection Prevention Skin Health
Asepsis Skin Care & Protection
Sterilization Tapes & Secural
Preps & Disinfection Wound Care
Skin Closure

Assessment & Therapy Food Safety
Electrodes & Plates Food Bacterial Testing
Immobilization Food Pathogen Testing
Auscultation Food Sample Prep


Medical Division Operations
A broad portfolio in clinically important growth segments:
– Infection Prevention
– Skin Health
– Patient Assessment
– Food Safety

Global business – 55% of revenue & 63% of growth OUS
Dedicated sales coverage in more than 60 countries
R&D resources on 5 continents
Major manufacturing in 10 countries


Medical Division Growth Drivers
Investing for accelerated new product flow
Expanded sales coverage U.S. and Europe
New push into Alternate Care
Accelerating growth in developing countries
– Products
– Coverage
– Manufacturing

Acquisitions and technology licensing


Medical Key New Products For 2006
Comfort Layer
3M One Comfortte) Layer
Compression (L ami na
Compression (L ami na te)
Lay erer
Littmann™ Lay

Step PU-Foa mm
PU-Foa

Electronic Patient Coban LF
Coban LF
Stethoscopes
Prep
CobanTM 2 Layer
modified Coban LL F
modified Coban F
Compression
(much l ess stre tch, more
and he avlier Denier -simore
(much ess stre tch, ze
and he av ier Denier -si ze
Spa ndex fi la ments)

System
Spa ndex fi la ments)

ClozeXTM Wound Closure

Tegaderm™ Ag
Ioban™ 2 Frame
Mesh Dressing
with Silver Delivery
Scotchcast™ Wet or Tegaderm™ on Roll
Dry Cast Padding

Licensing Agreement – ClozeXTM Medical
Unique design for fast application and closure
Good cosmetic results
Less infection potential than invasive sutures or
staples
Reduced skin trauma and patient discomfort
Sutures ClozeX
Used by variety of surgeons and
physicians
- plastic and reconstruction
Suture closure at 6 months post-op ClozeX closure at 6 months post-op

- cardiothoracic
- vascular
- OB-GYN
- general surgery
- orthopedics
- dermatology
- emergency medicine

Medical Alternate Care Growth
Market Drivers Portfolio Strength
Care moving to outside of hospital Tape Secural
Growth in Chronic Wounds - aging Acute and Active Dressings
population, diabetes & obesity
Skin Care
Regulatory/reimbursement activity Advanced Wound Care
increasing in Chronic Care
Compression
Growth Initiatives
Invest – Dedicated US Coverage
Expand European Coverage
New Products
Build Brand


High Growth Space – Food Processing Safety

Market Drivers Leveraging Health Care Growth Initiatives
Growing Awareness of Integrated Detection, Monitoring Investing in Global
Food Safety – Globally & Antimicrobial Technology Marketing/Sales Coverage
Increased Regulatory Development & Testing Expertise Expanding US Manufacturing
Vigilance
Global Regulatory & Quality Establishing Manufacturing
International Market Monitoring Systems in Asia
Expansion
Regulated Manufacturing Investing in Technology
Customer Expectation Processes
Accessing Technology
of Safe Food
Through Partnerships
Globalization of
Food Processing


Dental and Orthodontics Portfolio

FiltekTM Supreme Composite
ImpregumTM
ClarityTM Filling Materials
Impression Materials
Orthodontic Appliances

ProtempTM 3 LavaTM Frame and Bridge
OMNI
Temporization Materials Preventive Products Digital Ceramic Systems


Dental & Orthodontics Operations
A broad portfolio in both established and newer,
high-growth segments:
– Restoratives
– Prosthodontics
• Including Laboratory and Digital Dentistry
– Orthodontics
– Prevention

Global business – 65% of revenue OUS
Dedicated sales coverage in more than 60 countries
Major operations centers in the U.S. and Germany


Dental & Orthodontics Growth Drivers
Investing for accelerated new product flow
Expanded sales coverage globally
Accelerating growth in developing countries
– Products
– Manufacturing

Enter high-growth market spaces
Acquisitions and technology licensing


Dental & Orthodontics
Key New Products For 2006

SmartClip TM FiltekTM Supreme Plus Vitrebond TM Plus ImprintTM
Self-Ligating Brackets Composites Liner/Base Impression Materials

LavaTM Finished Bridge LavaTM Ceram Overlay ParadigmTM C Glass Ceramic Blocks

Digital Ceramic Systems


High Growth Space – Preventive Oral Care

Acquisition Of OMNII


High Growth Space – Digital Dentistry


Drug Delivery Systems Division
Leveraging 3M Technologies And Manufacturing Processes


Attractiveness Of Drug Delivery Systems

Differentiating from
competing products

Commercial value Increasing returns
Extending patent life of drug delivery on R&D

Improving efficacy,
convenience, compliance,
Reducing side effects


Drug Delivery Systems Key Growth Drivers
Market transition from CFC to HFA inhalers
Growing attractiveness of global emerging markets
Increased interest in transdermal delivery as a
product enhancement opportunity
Demand for patient friendly macromolecule
delivery technologies


Hospital Information Systems Division
3M HIS Solutions

Medical Record Compliance and
Patient Billing Codes
Patient
Assessment for Billing Edits for
Record post- Transferred to
Hospital
Billing - 3M Decreased A/R
discharge Billing System
Care
Code Finder Cycle & Accuracy

Leader in a critical segment - accuracy of reimbursements
- Pioneer in coding and grouping
- Leading expertise and technology
- Scale
Pay for Performance pressures increasing
- Severity adjusted reimbursement opportunity
- 3M well positioned
Market pressures are global - opportunity in selected OUS countries
Acquisition opportunities in adjacent segments


Health Information Systems Acquisition

3M HIS has entered into a definitive agreement to acquire SBG GmbH
based in Berlin, Germany
SBG is a leading developer of coding and grouping software for the
German health information technology market
The Company participated in the development of the German coding
and grouping classification system used by hospitals for reimbursement
SBG’s products are complementary to 3M’s existing portfolio and
expands our footprint in Germany
SBG’s technology also serves as a catalyst to expand our presence in
Europe, Asia Pacific and other developing markets
SBG provides 3M with a regional development center of excellence to
better serve our European customers
This acquisition also solidifies key relationships with leading European
systems integrators


Health Care Business Summary
Health Care Portfolio
Dental & Drug Delivery HIS
Medical Orthodontics Systems

Strategies To Accelerate Growth
Drive additional organic growth with key investments
Accelerate in high growth market spaces with new organic platforms
Rapidly penetrate in developing countries
Step up the pace on acquisitions, especially synergistic bolt-ons

rad T. Sauer Executive Vice President, Health Care Business

Recomendados

Recomendados

Mais conteúdo relacionado

Mais procurados

Mais procurados (18)

Destaque

Destaque (20)

Semelhante a rad T. Sauer Executive Vice President, Health Care Business

Semelhante a rad T. Sauer Executive Vice President, Health Care Business (20)

Mais de finance10

Mais de finance10 (16)

Último

Último (20)

rad T. Sauer Executive Vice President, Health Care Business